help button home button Endocrine Society JCEM
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit a related Letter to the Editor
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Azizi, M.
Right arrow Articles by Ménard, J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Azizi, M.
Right arrow Articles by Ménard, J.
The Journal of Clinical Endocrinology & Metabolism Vol. 85, No. 11 4331-4337
Copyright © 2000 by The Endocrine Society


Original Studies

Influence of the M235T Polymorphism of Human Angiotensinogen (AGT) on Plasma AGT and Renin Concentrations after Ethinylestradiol Administration1

Michel Azizi, Marie-Charlotte Hallouin, Xavier Jeunemaitre, Than Tam Guyene and Joël Ménard

Centre d’Investigations Cliniques 9201 (M.A., M.-C.H., T.T.G., J.M.) and Laboratoire de Biologie Moléculaire (X.J.), Assistance Publique des Hôpitaux de Paris (AP-HP) et INSERM, Hôpital Européen Georges Pompidou, 75908 Paris, France

Address all correspondence and requests for reprints to: Michel Azizi, Centre d’Investigations Cliniques 9201, Hôpital Européen Georges Pompidou, 20–40 rue Leblanc, 75908, Paris Cedex 15, France. E-mail: michel.azizi{at}egp.ap-hop-paris.fr

The T235 allele of the angiotensinogen (AGT) gene is associated with plasma AGT concentration and pregnancy-induced hypertension. The aim of this study was to compare changes in the circulating renin-angiotensin system after short-term (2 days) and repeated (7 days) administration of 50 µg ethinylestradiol (EE) in homozygous normotensive men (TT and MM). After repeated EE administration, renin stimulation was induced by a single oral dose of 40 mg furosemide, followed by 50 mg captopril, 12 h later. The short-term administration of EE did not induce a significant differential genotype-dependent increase in AGT concentration. In the 7-day study, TT subjects had higher peak plasma AGT concentrations than MM subjects. The more pronounced AGT increase in TT subjects resulted in similar plasma renin activity at a lower plasma active renin concentration, with a higher plasma renin activity/active renin ratio. The difference between genotypes in renin secretion resulted in readjustment of angiotensins production. In conclusion, the T235 allele of the AGT gene is associated with greater stimulation of AGT secretion in plasma after EE administration. In the short-term, complete readjustment of the circulating renin-angiotensin system occurs, through a decrease in renin release, which blunts the effects of the increase in AGT concentration.




This article has been cited by other articles:


Home page
In VivoHome page
A. GLUBA, M. BANACH, D. P. MIKHAILIDIS, and J. RYSZ
Genetic Determinants of Cardiovascular Disease: The Renin-Angiotensin-Aldosterone System, Paraoxonases, Endothelin-1, Nitric Oxide Synthase and Adrenergic Receptors
In Vivo, September 1, 2009; 23(5): 797 - 812.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
R. Sitruk-Ware, G. Plu-Bureau, J. Menard, J. Conard, S. Kumar, J.-C. Thalabard, B. Tokay, and P. Bouchard
Effects of Oral and Transvaginal Ethinyl Estradiol on Hemostatic Factors and Hepatic Proteins in a Randomized, Crossover Study
J. Clin. Endocrinol. Metab., June 1, 2007; 92(6): 2074 - 2079.
[Abstract] [Full Text] [PDF]


Home page
Endocr. Rev.Home page
J. R. Lindsay and L. K. Nieman
The Hypothalamic-Pituitary-Adrenal Axis in Pregnancy: Challenges in Disease Detection and Treatment
Endocr. Rev., October 1, 2005; 26(6): 775 - 799.
[Abstract] [Full Text] [PDF]


Home page
HypertensionHome page
A. A. Sethi, B. G. Nordestgaard, M.-L. M. Gronholdt, R. Steffensen, G. Jensen, and A. Tybjaerg-Hansen
Angiotensinogen Single Nucleotide Polymorphisms, Elevated Blood Pressure, and Risk of Cardiovascular Disease
Hypertension, June 1, 2003; 41(6): 1202 - 1211.
[Abstract] [Full Text] [PDF]


Home page
Physiol. GenomicsHome page
B. Cvetkovic, H. L. Keen, X. Zhang, D. Davis, B. Yang, and C. D. Sigmund
Physiological significance of two common haplotypes of human angiotensinogen using gene targeting in the mouse
Physiol Genomics, December 3, 2002; 11(3): 253 - 262.
[Abstract] [Full Text] [PDF]


Home page
HeartHome page
J R Ortlepp, H P Vosberg, S Reith, F Ohme, N G Mahon, D Schroder, H G Klues, P Hanrath, and W J McKenna
Genetic polymorphisms in the renin-angiotensin-aldosterone system associated with expression of left ventricular hypertrophy in hypertrophic cardiomyopathy: a study of five polymorphic genes in a family with a disease causing mutation in the myosin binding protein C gene
Heart, March 1, 2002; 87(3): 270 - 275.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals
Copyright © 2000 by The Endocrine Society